Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: BNT162b2

Aventiv Research Seeks Teenage Participants for Pfizer Vaccine Study in Columbus, Ohio

A trial site organization previously profiled by TrialSite seeks teenagers in the Columbus, Ohio, area to study the safety and […]

Aventiv Research Seeks Teenage Participants for Pfizer Vaccine Study in Columbus, Ohio
2 months ago
Share

POTUS Tells Commissioner Hahn: Approved Pfizer/BioNTech Vaccine or ‘You’re Fired’ & Hahn Opts to Keep His Job

The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) for a vaccine for the prevention […]

POTUS Tells Commissioner Hahn: Approved Pfizer/BioNTech Vaccine or ‘You're Fired’ & Hahn Opts to Keep His Job
3 months ago
Share

State of Virginia Conducts Pfizer/BioNTech COVID-19 Vaccine Test Run with Inova Health

Virginia state epidemiologist Lilian Peake informed legislators this week that the Virginia Department of Health was in the process of […]

State of Virginia Conducts PfizerBioNTech COVID-19 Vaccine Test Run with Inova Health
3 months ago
Share

Henry Ford Health System Anticipates & Now Ready with 12 Super Freezers to Distribute Both Moderna & Pfizer/BioNTech Vaccines by Dec 1

One of the nation’s prominent metropolitan-based health care systems has invested in advanced refrigeration systems to immediately prepare for potentially […]

Henry Ford Health System Anticipates & Now Ready with 12 Super Freezers to Distribute Both Moderna & Pfizer/BioNTech Vaccines by Dec 1
3 months ago
Share

Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their […]

Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
4 months ago
Share

SUNY Upstate’s Dr. Stephen Thomas Selected as PI for Pfizer/BioNTech Phase 3 Vaccine Trial

New York State Governor Andrew M. Cuomo recently announced the appointment of SUNY Upstate Medical University’s Stephen Thomas, MD, as […]

SUNY Upstate’s Dr. Stephen Thomas Selected as PI for PfizerBioNTech Phase 3 Vaccine Trial
4 months ago
Share

Interim Analysis of Pfizer & BioNTech mRNA-based Vaccine Targeting COVID-19: 90% Effective!

Pfizer (NYSE:PFE) and BioNTech SE (Nasdaq: BNTX) report that their mRNA-based vaccine candidate BNT162b2 targeting SARS-CoV-2 evidences strong efficacy against […]

Interim Analysis of Pfizer & BioNTech mRNA-based Vaccine Targeting COVID-19 90% Effective!
4 months ago
Share

Reports out of Ireland that Pfizer/BioNTech’s BNT162b2 Very Close to FDA & EMA EUA

Reports out of Ireland suggest that the first COVID-19 vaccine out of the West could be available in Ireland in […]

Reports out of Ireland that PfizerBioNTech’s BNT162b2 Very Close to FDA & EMA EUA
4 months ago
Share

Pfizer to Commence First COVID-19 Vaccine Study Involving Minors: Cincinnati Children’s Hospital Trial Site Discussion

Health professionals’ concerns increasingly turned to the young as potential spreaders of COVID-19. Now Pfizer will commence a clinical trial testing […]

Pfizer to Commence First COVID-19 Vaccine Study Involving Minors Cincinnati Children’s Hospital Trial Site Discussion
5 months ago
Share

Nearing End of Study Pfizer/BioNTech Shut Down Most Trial Sites, Focus Dozen on Minority Recruitment

The Pfizer/BioNTech partnership, sponsoring the Phase 3 clinical trial investigating the safety and efficacy of COVID-19 vaccine candidate BNT162b2, nears […]

Nearing End of Study PfizerBioNTech Shut Down Most Trial Sites, Focus Dozen on Minority Recruitment
5 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.